Meningococcal Meningitis
📧 Sign up to get email alerts when something new happens for Meningococcal Meningitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine [Phase 3]
A Phase 3 trial evaluating immune response to meningococcal vaccination in children who previously received a MenACWY conjugate vaccine; res…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Evaluating the Comparative Safety and Immunogenicity of Three Lots of Novartis Meningococcal C Conjugate Vaccine in Healthy Toddlers [Phase 2]
Phase 2 trial results evaluating safety and immunogenicity of three lots of Novartis Meningococcal C Conjugate Vaccine in healthy toddlers.
-
CLINICAL_TRIALS trial_result · 2014-03-24Clinical Trial Update: A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants [Phase 3]
A Phase 3 trial evaluating the safety and immune response of Novartis' meningococcal ACWY vaccine in infants has completed, with results pos…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults [Phase 3]
Phase 3b, randomized, open-label trial completed to evaluate safety and immunogenicity of select travel vaccines administered concurrently w…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Assessment of Antibody Persistence at Eighteen Months After the Completion of the Vaccination Course in Study V72P10 [Phase 2, Phase 3]
Phase 2/3 clinical trial update assessing antibody persistence 18 months after vaccination with the V72P10 candidate meningococcal vaccine.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine [Phase 3]
A Phase 3 study evaluating the safety and immune response of a combined Hepatitis A/B vaccine with the MenACWY-CRM meningococcal conjugate v…
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents [Phase 4]
A Phase 4 randomized study evaluating immunogenicity and safety of co-administering HPV and Tdap vaccines with MenACWY in adolescents, with …
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine [Phase 3]
Phase 3 trial evaluating persistence of anti-meningococcal bactericidal antibodies in adolescents previously vaccinated with a MenACWY conju…
-
CLINICAL_TRIALS trial_result · 2013-11-07Clinical Trial Update: Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers [Phase 3]
Phase 3 clinical trial update evaluating safety and immunogenicity after one or two doses of Novartis Meningococcal ACWY Conjugate Vaccine i…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months) [Phase 2]
Phase 2 trial update assessing immunogenicity and safety of MenACWY vaccine in infants at 6 and 12 months.
-
CLINICAL_TRIALS trial_result · 2013-05-28Clinical Trial Update: Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects [Phase 3]
Phase 3 trial evaluating a single-dose SP284 meningococcal polysaccharide diphtheria toxoid conjugate vaccine in Japanese subjects has compl…
-
CLINICAL_TRIALS trial_result · 2013-02-21Clinical Trial Update: Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in Infants [Phase 2]
Phase 2 trial evaluating tolerance of a conjugate meningococcal C vaccine in infants has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis [Phase 1]
Phase 1 safety study of a meningococcal polysaccharide diphtheria toxoid conjugate vaccine covering serogroups A, C, Y and W-135 has complet…
-
CLINICAL_TRIALS trial_result · 2012-10-16Clinical Trial Update: A Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of MenACWY in Adolescents and Adults in Korea [Phase 3]
This Phase 3 trial evaluated the immunogenicity and safety of the MenACWY meningococcal conjugate vaccine in adolescents and adults in Korea…
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination [Phase 2]
Phase 2 clinical trial assessing antibody persistence and response to re-vaccination with Menactra or Menomune three years after initial men…
-
CLINICAL_TRIALS trial_result · 2011-10-24Clinical Trial Update: Immunogenicity and Safety of Different rMenB Plus MenACWY Formulations in Adolescents [Phase 2]
A Phase 2 trial evaluating the immunogenicity and safety of several rMenB Plus MenACWY vaccine formulations in adolescents has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-13Clinical Trial Update: A Study to Evaluate the Persistence and Immune Response to a Booster Dose of MenACWY [Phase 2]
A Phase 2 trial assessing how long the immune response lasts and the immune response after a booster dose of the MenACWY meningococcal vacci…
-
CLINICAL_TRIALS trial_result · 2011-08-23Clinical Trial Update: Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL® [Phase 2]
A Phase 2 trial evaluated concomitant administration of Menactra with a fifth dose of DAPTACEL in children aged 4 to 6 years. The study has …
-
CLINICAL_TRIALS trial_result · 2011-08-23Clinical Trial Update: Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults [Phase 1, Phase 2]
Phase 1/2 safety and blood collection study of a meningococcal B vaccine (RLP2086) in adults has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers [Phase 3]
This Phase 3 trial evaluated the immunogenicity and safety of pediatric vaccines administered with Menactra in healthy toddlers, with result…
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers [Phase 3]
A Phase 3 study evaluated two doses of Menactra meningococcal conjugate vaccine in healthy toddlers. The trial is completed and results were…
-
CLINICAL_TRIALS trial_result · 2010-10-04Clinical Trial Update: A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents [Phase 3]
Phase 3 study evaluating the safety and immune response of the Novartis Meningococcal ACWY Conjugate Vaccine in adolescents has completed wi…
-
CLINICAL_TRIALS trial_result · 2010-09-24Clinical Trial Update: A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults [Phase 3]
Phase 3 trial evaluating the safety and immune response of the Novartis Meningococcal ACWY conjugate vaccine (Menveo) in US adolescents and …
-
CLINICAL_TRIALS trial_result · 2010-08-04Clinical Trial Update: A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults [Phase 3]
Phase 3 trial update evaluating safety and immune response of the Novartis meningococcal ACWY vaccine in healthy adults. The study is comple…
-
CLINICAL_TRIALS trial_result · 2010-03-25Clinical Trial Update: Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years [Phase 1, Phase 2]
Phase 1/2 exploratory trial assessing safety and immunogenicity of Menactra and Menomune in people aged 56 and older; results were posted in…